Trial Profile
A Phase II Study of Cetuximab, Carboplatin and Radiotherapy for locally advanced head and neck squamous cell carcinoma
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 16 Dec 2020
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Cetuximab (Primary)
- Indications Head and neck cancer
- Focus Adverse reactions
- 19 Jan 2016 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 16 Nov 2015 Planned End Date changed from 1 Oct 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov.
- 17 Aug 2015 Planned End Date changed from 1 Jul 2015 to 1 Oct 2015, as reported by ClinicalTrials.gov.